1-4 of 4
Steve O'Brien
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

PTCH1 Expression At Diagnosis Reliably Predicts Treatment Failure in Imatinib-Treated Chronic Myeloid Leukaemia Patients

Juan M. Alonso-Dominguez, Sr., MD, Jacob Grinfeld, MD, Mary Alikian, David Marin, Alistair Reid, PhD, Mustafa Daghistani, Jane Apperley, John M Goldman, MD, Corinne Hedgley, Steve O‘Brien, Richard E. Clark, MD, Letizia Foroni, Gareth Gerrard, PhD
Journal: Blood
Blood (2012) 120 (21): 875.
https://doi.org/10.1182/blood.V120.21.875.875
Published: 2012
Journal Articles

Outcome of Patients with Chronic Myeloid Leukemia After Allogeneic Stem Cell Transplantation in Europe; Data From the EUTOS for CML Registry

Susanne Saussele, MD, Verena Hoffmann, MA., Doris Lindörfer, Andreas Hochhaus, MD, Francisco Cervantes, MD, Gert Ossenkoppele, MD, PhD, Henrik Hjorth-Hansen, MD, Steve O'Brien, PhD, Jiri Mayer, MD, Karel Indrak, Andrzej Hellmann, MD, Adriana Colita, MD, Anna Turkina, MD, PhD, Andrey Zaritskey, Juan Luis Steegmann, MD, PhD, David Marin, Markus Pfirrmann, PhD, Michele Baccarani, MD, Joelle Guilhot, Joerg Hasford, MD, Carmen Piccolo, MD, Bengt Simonsson, MD, PhD, Rüdiger Hehlmann, MD, Gianantonio Rosti, MD
Journal: Blood
Blood (2011) 118 (21): 1688.
https://doi.org/10.1182/blood.V118.21.1688.1688
Published: 2011
Journal Articles

Survival advantage from imatinib compared with the combination interferon-α plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trials

Clinical Trials & Observations
Lydia Roy, Joëlle Guilhot, Tillmann Krahnke, Agnès Guerci-Bresler, Brian J. Druker, Richard A. Larson, Steve O'Brien, Charlene So, Giorgio Massimini, François Guilhot
Journal: Blood
Blood (2006) 108 (5): 1478–1484.
https://doi.org/10.1182/blood-2006-02-001495
Published: 2006
Journal Articles

Retrospective Comparison of Imatinib Versus Interferon Plus Cytarabine (IFN/Ara-c) for Chronic Myelogenous Leukemia (CML) Patients in Chronic Phase (CP).

Francois Guilhot, MD, Lydia Roy, MD, Joelle Guilhot, BS, Tillmann Krahnke, BSR, Agnes Guerci, MD, Brian Druker, MD, Richard Larson, MD, Steve O’Brien, MD, Charlene So, PharmD, Giorgio Massimini, MD
Journal: Blood
Blood (2005) 106 (11): 165.
https://doi.org/10.1182/blood.V106.11.165.165
Published: 2005